Our analyses showed that with greater tau pathology, there was reduced neurite density as well as a reduction in the orientation of the neurites, demonstrating a reduction in diffusion properties in regions impacted by AD-related tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.